Mindray Medical International Announces First Quarter 20...(he first quarter 2007. First quart...)

quarter 2007. First quarter 2008 GAAP diluted earnings per share was

RMB1.59 (US$0.23). First quarter 2008 income tax expense was RMB40.8

million (US$5.8 million), representing an effective tax rate of 18.5%

compared to a 15.7% effective tax rate in the first quarter 2007, or an

increase of 78.6% from RMB22.9 million (US$3.0 million) in the first

quarter 2007.

-- Mindray provides gross margin, operating margin, net income and

earnings per share on a non-GAAP basis that exclude non-cash, share-

based compensation expense and acquired intangible assets amortization

expense to enable investors to better assess the Company's operating

performance. The non-GAAP measures are described below and reconciled

to the corresponding GAAP measure in the section below titled ''Use of

Non-GAAP Financial Measures.''

''We delivered another quarter of strong results both in China and international markets,'' said Mr. Xu Hang, Mindray's chairman and co-chief executive officer. ''During the quarter, we successfully acquired Datascope Corporation's patient monitoring business, bringing us one step closer to our goal of becoming a leading global medical device provider, which will allow us to make high-quality and affordable medical devices available to the greatest number of doctors and hospitals in China and in the world.''

The Company develops and manufactures over 40 products which are available in more than 140 countries.

''Despite a challenging currency environment, we achieved high growth in international markets that was widespread across geographies and well balanced between product segments while maintaining a high gross margin,'' added Mr. Li Xiting, Mindray's president and co-chief executive officer. "In our home market, we delivered more than 40 percent growth in sales for the fourth consecutive quarter. With a world-class R&D team and
'/>"/>